California Public Employees Retirement System
NVLN

California Public Employees Retirement System’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

California Public Employees Retirement System’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-39,891
Closed -$28K – 3460
2019
Q4 		$28K Hold
39,891
– – ﹤0.01% 3389
2019
Q3 		$29K Hold
39,891
– – ﹤0.01% 3217
2019
Q2 		$31K Hold
39,891
– – ﹤0.01% 3212
2019
Q1 		$49K Hold
39,891
– – ﹤0.01% 3141
2018
Q4 		$34K Hold
39,891
– – ﹤0.01% 3190
2018
Q3 		$118K Hold
39,891
– – ﹤0.01% 3130
2018
Q2 		$147K Hold
39,891
– – ﹤0.01% 3081
2018
Q1 		$140K Hold
39,891
– – ﹤0.01% 3067
2017
Q4 		$124K Hold
39,891
– – ﹤0.01% 3103
2017
Q3 		$280K Hold
39,891
– – ﹤0.01% 2892
2017
Q2 		$368K Hold
39,891
– – ﹤0.01% 2757
2017
Q1 		$428K Sell
39,891
-601
-1% -$6.14K ﹤0.01% 2719
2016
Q4 		$341K Buy
+40,492
New +$359K ﹤0.01% 2873

California Public Employees Retirement System's NVLN Position: Q1 2020 in Review

California Public Employees Retirement System sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q1 2020, closing a stake of 39,891 shares — an estimated $28K sold.

California Public Employees Retirement System first reported a position in NVLN in Q4 2016 and held it in 13 quarters. The position peaked at $428K in Q1 2017. 1 fund tracked by Wall St. Rank holds NVLN as of Q1 2020.

  • California Public Employees Retirement System reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q1 2020 after selling out during the quarter.
  • California Public Employees Retirement System sold 39,891 Novelion Therapeutics Inc. Common Shares shares in Q1 2020, an estimated $28K.
  • California Public Employees Retirement System first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2016 and held it in 13 quarters.
  • California Public Employees Retirement System's Novelion Therapeutics Inc. Common Shares position peaked at $428K in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q1 2020.

Based on California Public Employees Retirement System's 13F filing for Q1 2020, filed 12 May 2020.